WHO ICTRP trial
The role of naltrexone in opioid toxicity
IRCT2012062910133N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT2012062910133N1 |
|---|---|
| Public title | The role of naltrexone in opioid toxicity |
| Scientific title | The efficacy of oral naltrexone to maintain normal ventilation after acute methadone Poisoning in Opioid non-dependent Patients |
| Primary sponsor | Loghman-Hakim Toxicological Reserch Center dependent to Shahid-Beheshti University |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Acute Opioids Toxicity. Mental and behavioural disorders due to use of opioids;Mental and behavioural disorders due to use of opioids |
| Interventions | Intervention 1: Intervention group; After emergency management (if needed) the patients in intervention group will take a single dose of 50mg naltrexone orally . During the hospital stay, the prevalence of respiratory depression or… |
| Registration date | Mar 22, 2013 |
| Target size | 60 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: